2016 Hyundai Equus Signature
5.0 L • V8 • RWD • AT
KMHGH4JH4GU105044
Sales history: 1
Highlights
Condition
Run and drive
Seller
Insurance • GEICO
Key included
Yes
Docs
Good
History
1 record
Drive
5.0 L • V8 • RWD • AT
Odometer
145,500 mi ≈ 234,159 km
Primary damage
Undercarriage
Docs
MD • Salvage >75% Damage
Extra
Auction
VIN
KMHGH4JH4GU105044
Lot number
62558105
Copart
Sale status
Sold
Seller type
Insurance
Seller
GEICO
Location
Baltimore, MD
Description
Fuel type
Gasoline
Body color
Black
Body type
Sedan
Generation
VI
Trim
Signature
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Hyundai models
2016 Hyundai Equus Signature • 5.0 L • V8 • RWD • Automatic • Copart Lot: 62558105 • VIN: KMHGH4JH4GU105044
Find out more about this 2016 Hyundai Equus Signature, available at the Copart salvage car auction as lot #62558105 in Baltimore, MD. This car has Undercarriage main damage. It is listed with Run and drive start condition code. Odometer shows 145,500 mi. This Black Hyundai Equus Sedan is equipped with Gasoline 5.0 L engine, RWD drivetrain, Automatic transmission. Check the vehicle history report for KMHGH4JH4GU105044 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
